- BioLife Solutions is a leading company focused on the cell therapy market.
- The company has demonstrated strong growth and market adoption even through COVID.
- The company has a differentiated technology platform that will allow them to take share over time.
- Valuation is healthy but given the company's product leadership and addressable market size, I believe there is still significant room for the stock to appreciate.
- Based on my 40x revenue multiple, I believe there is 29% upside from levels today.
For further details see:
BioLife Solutions: Leading Life Science Tools Play